Literature DB >> 4279524

[Carcinogenic activity of 13 aryldialkyl triazenes in BD-rats (author's transl)].

R Preussmann, S Ivankovic, C Landschütz, J Gimmy, E Flohr, U Griesbach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4279524     DOI： 10.1007/bf00305031

Source DB:  PubMed          Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol        ISSN： 0084-5353


× No keyword cloud information.
  37 in total

1.  5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma.

Authors:  E Frei; J K Luce; R W Talley; V K Vaitkevicius; H E Wilson
Journal:  Cancer Chemother Rep       Date:  1972-10

2.  [Neurotropic carcinogenic effect of phenyldimethyltriazene on rats].

Authors:  H Druckrey; S Ivankovic; R Preussmann
Journal:  Naturwissenschaften       Date:  1967-04

3.  Studies on the mechanism of action of the tumour inhibitory triazenes.

Authors:  R C Audette; T A Connors; H G Mandel; K Merai; W C Ross
Journal:  Biochem Pharmacol       Date:  1973-08-01       Impact factor: 5.858

4.  Carcinogenicity and mechanism of action of 1-phenyl-3,3-dimethyltriazene.

Authors:  R Preussman
Journal:  Food Cosmet Toxicol       Date:  1968-12

5.  Preparation and antitumor activity of derivatives of 1-phenyl-3,3-dimethyltriazene.

Authors:  Y T Lin; T L Loo
Journal:  J Med Chem       Date:  1972-02       Impact factor: 7.446

6.  [Chemical constitution and mutagenic action. VI. Induction of dominant and recessive lethals by 1-aryl-3, 3-dialkyltriazenes in drosophila].

Authors:  E Vogel
Journal:  Mutat Res       Date:  1971-04       Impact factor: 2.433

Review 7.  5-(3,3-dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)--a new antitumor agent with activity against malignant melanoma.

Authors:  S K Carter; M A Friedman
Journal:  Eur J Cancer       Date:  1972-02       Impact factor: 9.162

8.  [ON THE REACTION OF MONONUCLEOTIDES WITH DIAZONIUM SALTS].

Authors:  H KOESSEL
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1965

9.  Mechanism of carcinogenesis with 1-aryl-3,3-dialkyl-triazenes. 3. In vivo methylation of RNA and DNA with 1-phenyl-3,3-( 14 C)-dimethyltriazene.

Authors:  F W Krüger; R Preussmann; N Niepelt
Journal:  Biochem Pharmacol       Date:  1971-03       Impact factor: 5.858

10.  Clinical study of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in carcinoma of the lung.

Authors:  J B Mizgerd; R M Amick; H M Hilal; M E Patno
Journal:  Cancer Chemother Rep       Date:  1971-02
View more
  12 in total

1.  Some aspects of metabolic activation of chemical carcinogens in relation to their organ specificity.

Authors:  H Bartsch; G P Margison; C Malaveille; A M Camus; G Brun; J M Margison; G F Kolar; M Wiessler
Journal:  Arch Toxicol       Date:  1977-12-30       Impact factor: 5.153

Review 2.  Structure-activity relations in carcinogenesis by N-nitroso compounds.

Authors:  W Lijinsky
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Effects of an inducer and an inhibitor of hepatic metabolism on the antitumor action of dimethyltriazenes.

Authors:  G Sava; S Zorzet; L Perissin; T Giraldi; L Lassiani
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 4.  N-methyl antitumour agents. A distinct class of anticancer drugs?

Authors:  D Newell; A Gescher; S Harland; D Ross; C Rutty
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  Structure/activity investigations in eight arylalkyltriazenes comparison of chemical stability, mode of decomposition, and SCE induction in Chinese hamster V79-E cells.

Authors:  R Thust; M Schneider; U Wagner; D Schreiber
Journal:  Cell Biol Toxicol       Date:  1991-04       Impact factor: 6.691

6.  DNA alkylation and neuro-oncogenesis by 3,3-dimethyl-1-phenyltriazene.

Authors:  H K Cooper; E Hauenstein; G F Kolar; P Kleihues
Journal:  Acta Neuropathol       Date:  1978-08-07       Impact factor: 17.088

7.  The nucleotide-permeable Escherichia coli cell, a sensitive DNA repair indicator for carcinogens, mutagens, and antitumor agents binding covalently to DNA.

Authors:  H W Thielmann; H Gersbach
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-09-28

8.  Comparative metabolism and carcinogenicity of ring-halogenated 3,3-dimethyl-1-phenyltriazenes.

Authors:  G F Kolar; M Habs
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

9.  [Differing carcinogenic activity in BD-rats of 1-phenyl- and 1-(pyridyl-3)-3,3-diethyltriazene after single doses on 1., 10. or 30. day of life (author's transl)].

Authors:  S Ivankovic; R Port; R Preussmann
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-08-30

10.  Microsomal mediated metabolism of dialkylaryltriazenes. II. Isolation and identification of metabolites of 3,3-dimethyl-1-phenyltriazene.

Authors:  B L Pool
Journal:  J Cancer Res Clin Oncol       Date:  1979-04-12       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.